Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Clinical trial NCT03806127 · COMPLETED
Trial details
- NCT number
- NCT03806127
- Sponsor
- Urovant Sciences GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-31
- Primary completion
- 2020-09-25
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.